. 2021 May 12;60(11):7974–7990. doi: 10.1021/acs.inorgchem.1c00507

Table 2. Half-Maximum Inhibitory Concentrations (IC₅₀, μM) of Compounds 2_Cl₂^iPr and 2_I₂ for A549 (Lung Adenocarcinoma) Human Cells, after Incubation of 24 h, Using Freshly Prepared Stock Solutions of the Complexes (Day 0), and 5- and 7-Day Aged Solutions of the Complexes^a.

cell line	compound	day 0	day 5	day 7
A549	2_Cl₂^iPr	24 ± 1	26 ± 10	27 ± 12
A549	2_I₂^iPr	48 ± 8	26 ± 8	9.5 ± 1.5
MCF7	2_I₂^iPr			12 ± 2

The IC₅₀ value (μM) of a 7-day-old DMSO solution of 2_I₂^iPr for MCF7 (breast carcinoma) human cells, after incubation for 24 h, is also included. The results are expressed as mean values ± SD out of three independent experiments.

Table 2. Half-Maximum Inhibitory Concentrations (IC50, μM) of Compounds 2Cl2iPr and 2I2 for A549 (Lung Adenocarcinoma) Human Cells, after Incubation of 24 h, Using Freshly Prepared Stock Solutions of the Complexes (Day 0), and 5- and 7-Day Aged Solutions of the Complexesa.

Table 2. Half-Maximum Inhibitory Concentrations (IC₅₀, μM) of Compounds 2_Cl₂^iPr and 2_I₂ for A549 (Lung Adenocarcinoma) Human Cells, after Incubation of 24 h, Using Freshly Prepared Stock Solutions of the Complexes (Day 0), and 5- and 7-Day Aged Solutions of the Complexes^a.